Copyright Reports & Markets. All rights reserved.

Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Severe Acute Respiratory Syndrome(SARS) Therapeutics

      • 1.1 Definition of Severe Acute Respiratory Syndrome(SARS) Therapeutics
      • 1.2 Severe Acute Respiratory Syndrome(SARS) Therapeutics Segment by Type
        • 1.2.1 Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 CEL-1000
        • 1.2.3 D-3252
        • 1.2.4 FDX-000
        • 1.2.5 INO-4500
        • 1.2.6 LCA-60
        • 1.2.7 Others
      • 1.3 Severe Acute Respiratory Syndrome(SARS) Therapeutics Segment by Applications
        • 1.3.1 Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
        • 1.3.4 Research Center
      • 1.4 Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Overall Market
        • 1.4.1 Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Revenue (2014-2025)
        • 1.4.2 Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Production (2014-2025)
        • 1.4.3 North America Severe Acute Respiratory Syndrome(SARS) Therapeutics Status and Prospect (2014-2025)
        • 1.4.4 Europe Severe Acute Respiratory Syndrome(SARS) Therapeutics Status and Prospect (2014-2025)
        • 1.4.5 China Severe Acute Respiratory Syndrome(SARS) Therapeutics Status and Prospect (2014-2025)
        • 1.4.6 Japan Severe Acute Respiratory Syndrome(SARS) Therapeutics Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Severe Acute Respiratory Syndrome(SARS) Therapeutics Status and Prospect (2014-2025)
        • 1.4.8 India Severe Acute Respiratory Syndrome(SARS) Therapeutics Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Severe Acute Respiratory Syndrome(SARS) Therapeutics
      • 2.3 Manufacturing Process Analysis of Severe Acute Respiratory Syndrome(SARS) Therapeutics
      • 2.4 Industry Chain Structure of Severe Acute Respiratory Syndrome(SARS) Therapeutics

      3 Development and Manufacturing Plants Analysis of Severe Acute Respiratory Syndrome(SARS) Therapeutics

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Severe Acute Respiratory Syndrome(SARS) Therapeutics
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Severe Acute Respiratory Syndrome(SARS) Therapeutics Production and Capacity Analysis
      • 4.2 Severe Acute Respiratory Syndrome(SARS) Therapeutics Revenue Analysis
      • 4.3 Severe Acute Respiratory Syndrome(SARS) Therapeutics Price Analysis
      • 4.4 Market Concentration Degree

      5 Severe Acute Respiratory Syndrome(SARS) Therapeutics Regional Market Analysis

      • 5.1 Severe Acute Respiratory Syndrome(SARS) Therapeutics Production by Regions
        • 5.1.1 Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Production by Regions
        • 5.1.2 Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Revenue by Regions
      • 5.2 Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption by Regions
      • 5.3 North America Severe Acute Respiratory Syndrome(SARS) Therapeutics Market Analysis
        • 5.3.1 North America Severe Acute Respiratory Syndrome(SARS) Therapeutics Production
        • 5.3.2 North America Severe Acute Respiratory Syndrome(SARS) Therapeutics Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Severe Acute Respiratory Syndrome(SARS) Therapeutics Import and Export
      • 5.4 Europe Severe Acute Respiratory Syndrome(SARS) Therapeutics Market Analysis
        • 5.4.1 Europe Severe Acute Respiratory Syndrome(SARS) Therapeutics Production
        • 5.4.2 Europe Severe Acute Respiratory Syndrome(SARS) Therapeutics Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Severe Acute Respiratory Syndrome(SARS) Therapeutics Import and Export
      • 5.5 China Severe Acute Respiratory Syndrome(SARS) Therapeutics Market Analysis
        • 5.5.1 China Severe Acute Respiratory Syndrome(SARS) Therapeutics Production
        • 5.5.2 China Severe Acute Respiratory Syndrome(SARS) Therapeutics Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Severe Acute Respiratory Syndrome(SARS) Therapeutics Import and Export
      • 5.6 Japan Severe Acute Respiratory Syndrome(SARS) Therapeutics Market Analysis
        • 5.6.1 Japan Severe Acute Respiratory Syndrome(SARS) Therapeutics Production
        • 5.6.2 Japan Severe Acute Respiratory Syndrome(SARS) Therapeutics Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Severe Acute Respiratory Syndrome(SARS) Therapeutics Import and Export
      • 5.7 Southeast Asia Severe Acute Respiratory Syndrome(SARS) Therapeutics Market Analysis
        • 5.7.1 Southeast Asia Severe Acute Respiratory Syndrome(SARS) Therapeutics Production
        • 5.7.2 Southeast Asia Severe Acute Respiratory Syndrome(SARS) Therapeutics Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Severe Acute Respiratory Syndrome(SARS) Therapeutics Import and Export
      • 5.8 India Severe Acute Respiratory Syndrome(SARS) Therapeutics Market Analysis
        • 5.8.1 India Severe Acute Respiratory Syndrome(SARS) Therapeutics Production
        • 5.8.2 India Severe Acute Respiratory Syndrome(SARS) Therapeutics Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Severe Acute Respiratory Syndrome(SARS) Therapeutics Import and Export

      6 Severe Acute Respiratory Syndrome(SARS) Therapeutics Segment Market Analysis (by Type)

      • 6.1 Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Production by Type
      • 6.2 Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Revenue by Type
      • 6.3 Severe Acute Respiratory Syndrome(SARS) Therapeutics Price by Type

      7 Severe Acute Respiratory Syndrome(SARS) Therapeutics Segment Market Analysis (by Application)

      • 7.1 Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption by Application
      • 7.2 Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption Market Share by Application (2014-2019)

      8 Severe Acute Respiratory Syndrome(SARS) Therapeutics Major Manufacturers Analysis

      • 8.1 CEL-SCI Corporation
        • 8.1.1 CEL-SCI Corporation Severe Acute Respiratory Syndrome(SARS) Therapeutics Production Sites and Area Served
        • 8.1.2 CEL-SCI Corporation Product Introduction, Application and Specification
        • 8.1.3 CEL-SCI Corporation Severe Acute Respiratory Syndrome(SARS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 GeneCure LLC
        • 8.2.1 GeneCure LLC Severe Acute Respiratory Syndrome(SARS) Therapeutics Production Sites and Area Served
        • 8.2.2 GeneCure LLC Product Introduction, Application and Specification
        • 8.2.3 GeneCure LLC Severe Acute Respiratory Syndrome(SARS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Humabs BioMed SA
        • 8.3.1 Humabs BioMed SA Severe Acute Respiratory Syndrome(SARS) Therapeutics Production Sites and Area Served
        • 8.3.2 Humabs BioMed SA Product Introduction, Application and Specification
        • 8.3.3 Humabs BioMed SA Severe Acute Respiratory Syndrome(SARS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Inovio Pharmaceuticals, Inc.
        • 8.4.1 Inovio Pharmaceuticals, Inc. Severe Acute Respiratory Syndrome(SARS) Therapeutics Production Sites and Area Served
        • 8.4.2 Inovio Pharmaceuticals, Inc. Product Introduction, Application and Specification
        • 8.4.3 Inovio Pharmaceuticals, Inc. Severe Acute Respiratory Syndrome(SARS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Nanotherapeutics, Inc.
        • 8.5.1 Nanotherapeutics, Inc. Severe Acute Respiratory Syndrome(SARS) Therapeutics Production Sites and Area Served
        • 8.5.2 Nanotherapeutics, Inc. Product Introduction, Application and Specification
        • 8.5.3 Nanotherapeutics, Inc. Severe Acute Respiratory Syndrome(SARS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Novavax, Inc.
        • 8.6.1 Novavax, Inc. Severe Acute Respiratory Syndrome(SARS) Therapeutics Production Sites and Area Served
        • 8.6.2 Novavax, Inc. Product Introduction, Application and Specification
        • 8.6.3 Novavax, Inc. Severe Acute Respiratory Syndrome(SARS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Phelix Therapeutics, LLC
        • 8.7.1 Phelix Therapeutics, LLC Severe Acute Respiratory Syndrome(SARS) Therapeutics Production Sites and Area Served
        • 8.7.2 Phelix Therapeutics, LLC Product Introduction, Application and Specification
        • 8.7.3 Phelix Therapeutics, LLC Severe Acute Respiratory Syndrome(SARS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Protein Sciences Corporation
        • 8.8.1 Protein Sciences Corporation Severe Acute Respiratory Syndrome(SARS) Therapeutics Production Sites and Area Served
        • 8.8.2 Protein Sciences Corporation Product Introduction, Application and Specification
        • 8.8.3 Protein Sciences Corporation Severe Acute Respiratory Syndrome(SARS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served

      9 Development Trend of Analysis of Severe Acute Respiratory Syndrome(SARS) Therapeutics Market

      • 9.1 Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Market Trend Analysis
        • 9.1.1 Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Severe Acute Respiratory Syndrome(SARS) Therapeutics Regional Market Trend
        • 9.2.1 North America Severe Acute Respiratory Syndrome(SARS) Therapeutics Forecast 2019-2025
        • 9.2.2 Europe Severe Acute Respiratory Syndrome(SARS) Therapeutics Forecast 2019-2025
        • 9.2.3 China Severe Acute Respiratory Syndrome(SARS) Therapeutics Forecast 2019-2025
        • 9.2.4 Japan Severe Acute Respiratory Syndrome(SARS) Therapeutics Forecast 2019-2025
        • 9.2.5 Southeast Asia Severe Acute Respiratory Syndrome(SARS) Therapeutics Forecast 2019-2025
        • 9.2.6 India Severe Acute Respiratory Syndrome(SARS) Therapeutics Forecast 2019-2025
      • 9.3 Severe Acute Respiratory Syndrome(SARS) Therapeutics Market Trend (Product Type)
      • 9.4 Severe Acute Respiratory Syndrome(SARS) Therapeutics Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Severe Acute Respiratory Syndrome(SARS) Therapeutics Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Severe Acute Respiratory Syndrome(SARS) Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Severe Acute Respiratory Syndrome(SARS) Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Severe Acute Respiratory Syndrome(SARS) Therapeutics market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Severe Acute Respiratory Syndrome(SARS) Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Severe Acute Respiratory Syndrome(SARS) Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        CEL-SCI Corporation
        GeneCure LLC
        Humabs BioMed SA
        Inovio Pharmaceuticals, Inc.
        Nanotherapeutics, Inc.
        Novavax, Inc.
        Phelix Therapeutics, LLC
        Protein Sciences Corporation

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        CEL-1000
        D-3252
        FDX-000
        INO-4500
        LCA-60
        Others

        Segment by Application
        Hospital
        Clinic
        Research Center

        Buy now